NDR for Institutional Investors (Introducing Subsidiary Verismo Therapeutics)
- IR event: NDR for domestic and foreign institutional investors in Seoul, May 6-8, 2026
- Purpose: Enhance investor understanding and corporate value
- Main content: Business explanation and Q&A on subsidiary Verismo Therapeutics
ADVERTISEMENT (250px+)
KOSDAQ Filing Information
- Filing: Holding of Investor Relations Conference (IR)
- Company: HLB innoVation (024850)
- Submission: HLB innoVation Co.,Ltd.
- Receipt: 04-30-2026
- Under KRX KOSDAQ Market Division